In the New York Times http://graphics8.nytimes.com/package…angenerics.pdf http://www.nytimes.com/2009/12/19/health/19patient.html?emc=eta1
The American Academy of Neurology reports: “The AAN opposes generic substitution of anticonvulsant drugs for the treatment of epilepsy without the attending physician’s approval. The FDA has allowed for significant differences between name-brand and generic drugs. This variation can be highly problematic for patients with epilepsy. Even minor differences in the composition of generic and name-brand anticonvulsant drugs for the treatment of epilepsy can result in breakthrough seizures.”
Please read the article, it’s from those who know best and truly have OUR interests at heart!
Other articles of interest:
Prescription Switching. Do You Know What You’re REALLY Getting? https://epilepsytalk.com/2013/02/12/prescription-switching-do-you-know-what-youre-really-getting-2/
Hello Generics, Goodbye Big-Name Drugs https://epilepsytalk.com/2011/10/25/hello-generics-goodbye-big-name-drugs/
Epilepsy Generics: Yes, No or Maybe So? https://epilepsytalk.com/2009/09/01/epilepsy-generics-yes-no-or-maybe-so/
To subscribe to Epilepsytalk.com and get the latest articles, go to the bottom box of the right column and click on “Sign me up!”